Residents met with urgent warnings after alarming hurricane season forecast: 'This outlook is a call to action'
NOAA officials say a combination of factors — including a neutral El Niño-Southern Oscillation, above-average ocean temperatures, and weak wind shear — is set to fuel the 60% chance that we'll see an "above-normal" Atlantic hurricane season, according to CBS News.
The outlet reported that forecasters may have reason to be even more confident in their predictions this year. A planned upgrade to NOAA's modeling is expected to boost the accuracy of tracking tropical systems and predicting their intensity by around 5%.
To improve preparedness and response, NOAA has also expanded its Global Tropical Hazards Outlook from a two-week to a three-week forecast window, the agency said, providing earlier warnings of possible tropical cyclone activity.
"In my 30 years at the National Weather Service, we've never had more advanced models and warning systems in place to monitor the weather," said NWS director Ken Graham in a statement, per CBS. "This outlook is a call to action: be prepared. Take proactive steps now to make a plan and gather supplies to ensure you're ready before a storm threatens."
The agency is forecasting between 13 and 19 named storms (compared to an average of around 14) and six to 10 hurricanes (compared to the average of seven).
CBS cited Colorado State University as another highly regarded source of hurricane predictions. The university's team concurs that the season will be a busy one, estimating a total of 17 named storms, including nine hurricanes.
Even if the 2025 Atlantic hurricane season defies all these expectations and falls short of average, storm experts are quick to their refrain: "It only takes one." And we don't have to think far back at all to find an example of just how destructive a hurricane can be.
Hurricane Helene struck the U.S. in late September last year. After the initial damage it inflicted on the Gulf Coast, the storm surged north, bringing strong winds to the Southeast and wringing out historic rainfalls in North Carolina. The storm killed at least 250 people in the U.S., becoming the deadliest hurricane to hit the country's mainland since Katrina in 2005. It also caused financial devastation for many families and municipalities.
Scientists have said that the overheating of our planet supercharged Helene, increasing the storm's rainfall by 10% and wind strength by 11%. An analysis of the 2024 hurricane season conducted by Climate Central found that "human-caused global warming" contributed to every named storm last year.
What would you do if natural disasters were threatening your home?
Move somewhere else
Reinforce my home
Nothing
This is happening already
Click your choice to see results and speak your mind.
Angela Colbert at NASA's Jet Propulsion Laboratory didn't disagree with this thinking in a 2022 post. "Due to global warming, global climate models predict hurricanes will likely cause more intense rainfall," Colbert wrote, "and have an increased coastal flood risk due to higher storm surge caused by rising seas."
Ditching dirty energy sources in favor of clean, renewable options can help cool down our planet and mitigate its effects, like extreme weather events and rising sea levels. A study by researchers at Cornell University has suggested that repurposing only 3.2% of U.S. cropland, currently used to grow corn for ethanol, could result in a more than threefold increase in solar power output nationwide.
Learning more about critical climate issues, especially together in affinity groups with the potential for local action, can help normalize the adoption of renewables and facilitate the pro-environment policies that can make scaled-up transition more realizable.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Can peptides really help erase wrinkles? Dermatologists weigh in
In you've shopped for any kind of skin care products over the past year, you've probably noticed peptides popping up everywhere. As the beauty world's trendiest, anti-aging ingredient du jour, these small chains of amino acids (which are the building blocks of proteins) are now present in everything from lip plumpers to hair-growth tonics. But experts say their most promising use is as part of an effective daily skin care routine, where research suggests they may in fact have a Botox-like effect on wrinkles by softening fine lines, building collagen and brightening and plumping wizened skin as they go. How do peptides work? "In skin care, peptides are used to mimic natural processes in the skin and encourage anti-aging effects like collagen production, skin repair and improv[ed] elasticity," says board-certified dermatologist and facial plastic surgeon Dr. Akshay Sanan. "As we age, collagen production declines, leading to wrinkles, sagging, and thinner skin. Signal peptides, like Matrixyl and copper peptides send messages to skin cells, essentially 'telling' them to produce more collagen, elastin and other structural proteins to keep the skin firm and plump." Sanan says peptides also strengthen the skin barrier, protecting against moisture loss and environmental damage. And, yes, "some peptides even have a 'Botox-like' effect by relaxing facial muscles and reducing the depth of wrinkles caused by repetitive movements," Sanan explains. Should you try peptides? Dermatologists I spoke with agreed that if you've reached an age when you're starting to spot wrinkles and collagen loss, it's worth adding peptides to your skin care regimen, if only for their plumping, moisturizing effects. In term of acting as a Botox-y wrinkle eraser, research suggests a quality peptide product will soften lines, though the result will be more subtle and less dramatic than that of a neurotoxin. "Collagen peptides do work to boost collagen production in the skin which may, over time, reduce the appearance of wrinkles," says Houston cosmetic surgeon Dr. Rukmini Rednam. What should I look for in a peptide serum? There are loads of types of peptides, but for the most bang for your skin care buck, experts recommend seeking out complexes with the most clinical data behind them, which essentially narrows things down to the Matrixyl 3000 blend and copper peptides. Both of which have some research to back up their claims, with benefits that include skin barrier support, wrinkle softening and complexion brightening. How should I use a peptide serum? Peptides are one of those skin care ingredients you can add to your routine both in the morning and at night. And, as is the case with any lighter-weight serum, for best absorption, these products should be applied after cleansing your face but before you slather on heavier creams like moisturizers and sunscreens. In terms of more detailed order of operations, you can combine peptides with vitamin C and layer them with retinoids, but most skin care experts say you shouldn't mix them with an exfoliating products. Our top 5 favorite peptide serums If you have Amazon Prime, you'll get free shipping, of course. Not yet a member? No problem. You can sign up for your free 30-day trial here. (And by the way, those without Prime still get free shipping on orders of $35 or more.) The reviews quoted above reflect the most recent versions at the time of publication.
Yahoo
29 minutes ago
- Yahoo
Warren Buffett's Next Big Buy? Why This Beaten-Down Blue Chip Stock Fits His Playbook Perfectly.
Key Points Buffett understands the business of this beleaguered insurer. He would likely find its financials appealing. Buffett would almost certainly like the stock's valuation. 10 stocks we like better than UnitedHealth Group › Warren Buffett has a lot of money burning a hole in his pocket. Technically, it's Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) pocket, but Buffett gets to decide how to use the cash. And when I say a lot of money, I mean a lot of money: Berkshire's cash position totaled nearly $348 billion at the end of the first quarter. The problem is that Buffett can't find many stocks to buy that meet his stringent investment criteria. However, I think there's one beaten-down blue chip stock that fits his playbook perfectly. A business Buffett understands Buffett has stated on multiple occasions, in various ways, that he will only invest in a business that he thoroughly understands. In his 1996 letter to Berkshire Hathaway shareholders, he wrote: "You don't have to be an expert on every company, or even many. You only have to be able to evaluate companies within your circle of competence." Probably no business is within Buffett's circle of competence more than insurance. Berkshire generates a significant portion of its revenue from its property and casualty business. But the core principles of running an insurance business are the same regardless of what type of insurance it is. The key to success is to effectively evaluate risk and charge premiums that cover that risk while making a profit. UnitedHealth Group (NYSE: UNH) is the largest health insurer in the United States. I don't doubt that Buffett knows its business quite well. After all, he bought a stake in UnitedHealth for Berkshire's portfolio in 2006 and owned the stock for three years. Financials Buffett would find appealing UnitedHealth Group's share price has plunged more than 50% this year. The company delivered lower-than-expected results in the first quarter. It initially cut full-year guidance and then withdrew the guidance altogether. However, I suspect that Buffett would still find UnitedHealth's financials appealing. Buffett has talked about the importance of return on equity (ROE) in the past. He has hinted that 20% is his preferred ROE threshold. UnitedHealth Group's ROE over the past 12 months was 22.7%. Despite its disappointing Q1 results, UnitedHealth Group's revenue still grew $9.8 billion year over year to $109.6 billion. The company also generated a profit of nearly $6.3 billion. It had nearly $34.3 billion in cash and cash equivalents with a manageable debt load. I think Buffett would focus on UnitedHealth's hard numbers more than he would Wall Street's expectations. A price Buffett almost certainly likes Why hasn't Buffett put more of Berkshire's massive cash stockpile to work? He can't find many stocks with attractive valuations. But UnitedHealth Group has a price Buffett almost certainly likes. The healthcare stock trades at roughly 12 times trailing 12-month earnings. UnitedHealth Group's earnings multiple was significantly higher when Buffett first initiated a position in early 2006. Of course, Buffett focuses on future earnings potential. Could he be worried that UnitedHealth Group's profits will continue to all? I don't think so. The company's primary issue is that costs for some of its Medicare Advantage plans were higher than expected. Buffett knows that insurers can easily address these kinds of problems in the next year by increasing premiums. He would likely believe UnitedHealth Group's prediction that the company will return to growth in 2026. Is Buffett buying UnitedHealth Group stock? I also don't know if Buffett is buying UnitedHealth Group stock. He could be content to sit on Berkshire's cash and leave it to Greg Abel to make any big moves after Buffett steps down as CEO at the beginning of next year. What I do know, though, is that UnitedHealth Group fits Buffett's playbook. And that playbook has been enormously successful through the years. Investors wanting to emulate Buffett might want to consider buying shares of the beaten-down blue chip stock while it's a bargain -- whether or not the "Oracle of Omaha" buys it himself. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $634,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,046,799!* Now, it's worth noting Stock Advisor's total average return is 1,037% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Keith Speights has positions in Berkshire Hathaway. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Warren Buffett's Next Big Buy? Why This Beaten-Down Blue Chip Stock Fits His Playbook Perfectly. was originally published by The Motley Fool
Yahoo
36 minutes ago
- Yahoo
A farewell to Ozzy, Coke's sugar high, another vaccine shake-up: The week in review
RFK shakes up vaccines again Health Secretary Robert F. Kennedy Jr. took another step toward overhauling the nation's vaccine policy when he approved the removal of thimerosal, a mercury-based preservative, from all flu vaccines despite widespread agreement in the medical community that the preservative is safe. Kennedy signed off on a recommendation from the Advisory Committee on Immunization Practices, a panel he replaced with his own appointed members in June, to stop distributing vaccines containing thimerosal, which has long been targeted by anti-vaccine groups. An operatic honor for Melania Republican lawmakers are working on a Kennedy Center production of their own: renaming the center's Opera House to the 'First Lady Melania Trump Opera House.' The House Appropriations Committee, whose spending bill funds the iconic performing arts venue in Washington, voted 33-25 for the change. Lawmakers have already agreed to spend $256.7 million on improvements to the center sought by President Donald Trump, who ousted much of the Kennedy Center's board after he took office and appointed himself chairman. He has criticized some of the center's performances and said in one visit that he 'never liked 'Hamilton' very much.' A sweet twist to the Cola wars Cane sugar: It's the real thing. A Coca-Cola made with cane sugar − not high-fructose corn syrup − is coming to the United States this fall, the company announced, just like the Coke you find overseas, including Mexico. (The long-running debate over which tastes better, U.S. Coke or Mexican Coke, has been a fierce one). The news doesn't come as a compete surprise; President Donald Trump had made a case for cane sugar Coke on social media in mid-July − 'You'll see. It's just better!' Also, not to be outdone, Pepsi announced it is launching Pepsi Prebiotic Cola this fall, in Original Cola and Cherry Vanilla, containing 5 grams of cane sugar and 3 grams of prebiotic fiber. Ozzy Osbourne, the 'Prince of Darkness,' is dead The heavy metal world has lost one of its most beloved characters, Ozzy Osbourne, at age 76, only weeks after reuniting with his original band, Black Sabbath, in England for a farewell show. Osbourne, who was infamous for his hard living (and for biting the head off a bat), exploded into stardom in a solo career and later branched into reality TV with MTV's 'The Osbournes' in the early 2000s. In 2020, he revealed he had Parkinson's disease. In a just-announced new memoir, 'Last Rites,' arriving Oct. 7, Osbourne says: 'Look, if it ends tomorrow, I can't complain. I've been all around the world. … I've done good, and I've done bad. But right now, I'm not ready to go anywhere.' Remembering Ozzy Osbourne: Life on the 'Crazy Train': The metal icon through the years All bets for 2026 are on Scottie Scheffler Scottie Scheffler, fresh off a dominating win at the British Open July 20, is at the top of his game, and you can expect he'll be there for awhile. Scheffler, 29, who also captured the PGA Championship in May and now needs only a U.S. Open victory to enter the elite group of golfers who have won the sport's grand slam of all four major championships, is now the odds-on favorite to win every major in 2026, according to BetMGM. Declared the gaming venture's Matt Wall: 'The comparisons with Tiger Woods certainly don't look out of place right now.' − Compiled by Robert Abitbol This article originally appeared on USA TODAY: A farewell to Ozzy, Coke's sugar high, the flu fight: Week in review
